CXCL1 and diabetic kidney disease: In essence, this research not only expands our comprehension of the mechanisms underpinning DKD but also illuminates a promising avenue for therapeutic intervention, suggesting that the modulation of YAP1 and CXCL1 may hold promise as therapeutic strategies in human DKD and offering renewed hope for patients grappling with this debilitating condition [60].